86 related articles for article (PubMed ID: 14710354)
21. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
Joo SS; Yoo YM
J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
[TBL] [Abstract][Full Text] [Related]
22. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
Fang J; Zhou Q; Shi XL; Jiang BH
Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
[TBL] [Abstract][Full Text] [Related]
23. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
[TBL] [Abstract][Full Text] [Related]
25. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
Li JC; Li R
Cancer Res; 2007 Sep; 67(18):8856-64. PubMed ID: 17875727
[TBL] [Abstract][Full Text] [Related]
26. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
[TBL] [Abstract][Full Text] [Related]
27. Proteasome inhibitors induce a p38 mitogen-activated protein kinase (MAPK)-dependent anti-apoptotic program involving MAPK phosphatase-1 and Akt in models of breast cancer.
Shi YY; Small GW; Orlowski RZ
Breast Cancer Res Treat; 2006 Nov; 100(1):33-47. PubMed ID: 16807678
[TBL] [Abstract][Full Text] [Related]
28. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
29. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis.
D'Ambrosio C; Ferber A; Resnicoff M; Baserga R
Cancer Res; 1996 Sep; 56(17):4013-20. PubMed ID: 8752172
[TBL] [Abstract][Full Text] [Related]
30. Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors.
Reiss K; Tu X; Romano G; Peruzzi F; Wang JY; Baserga R
Clin Cancer Res; 2001 Jul; 7(7):2134-44. PubMed ID: 11448933
[TBL] [Abstract][Full Text] [Related]
31. Antitumor effects of a soluble insulin-like growth factor I receptor in human ovarian cancer cells: advantage of recombinant protein administration in vivo.
Hongo A; Kuramoto H; Nakamura Y; Hasegawa K; Nakamura K; Kodama J; Hiramatsu Y
Cancer Res; 2003 Nov; 63(22):7834-9. PubMed ID: 14633710
[TBL] [Abstract][Full Text] [Related]
32. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo.
Resnicoff M; Abraham D; Yutanawiboonchai W; Rotman HL; Kajstura J; Rubin R; Zoltick P; Baserga R
Cancer Res; 1995 Jun; 55(11):2463-9. PubMed ID: 7758000
[TBL] [Abstract][Full Text] [Related]
33. The contradictions of the insulin-like growth factor 1 receptor.
Baserga R
Oncogene; 2000 Nov; 19(49):5574-81. PubMed ID: 11114737
[TBL] [Abstract][Full Text] [Related]
34. Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1).
Galvan V; Logvinova A; Sperandio S; Ichijo H; Bredesen DE
J Biol Chem; 2003 Apr; 278(15):13325-32. PubMed ID: 12556535
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect.
Reiss K; D'Ambrosio C; Tu X; Tu C; Baserga R
Clin Cancer Res; 1998 Nov; 4(11):2647-55. PubMed ID: 9829727
[TBL] [Abstract][Full Text] [Related]
36. Non-small cell lung cancer cell survival crucially depends on functional insulin receptors.
Frisch CM; Zimmermann K; Zilleßen P; Pfeifer A; Racké K; Mayer P
Endocr Relat Cancer; 2015 Aug; 22(4):609-21. PubMed ID: 26113601
[TBL] [Abstract][Full Text] [Related]
37. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production.
Lee SK; Kang JS; Jung DJ; Hur DY; Kim JE; Hahm E; Bae S; Kim HW; Kim D; Cho BJ; Cho D; Shin DH; Hwang YI; Lee WJ
J Cell Physiol; 2008 Jul; 216(1):180-8. PubMed ID: 18297687
[TBL] [Abstract][Full Text] [Related]
38. Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair.
Héron-Milhavet L; Karas M; Goldsmith CM; Baum BJ; LeRoith D
J Biol Chem; 2001 May; 276(21):18185-92. PubMed ID: 11278917
[TBL] [Abstract][Full Text] [Related]
39. PTEN inhibits cell proliferation and induces apoptosis by downregulating cell surface IGF-IR expression in prostate cancer cells.
Zhao H; Dupont J; Yakar S; Karas M; LeRoith D
Oncogene; 2004 Jan; 23(3):786-94. PubMed ID: 14737113
[TBL] [Abstract][Full Text] [Related]
40. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.
Metalli D; Lovat F; Tripodi F; Genua M; Xu SQ; Spinelli M; Alberghina L; Vanoni M; Baffa R; Gomella LG; Iozzo RV; Morrione A
Am J Pathol; 2010 Jun; 176(6):2997-3006. PubMed ID: 20395438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
